The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy

Journal of the American College of Cardiology

Volumn 57, Issue 20, 2011, Pages 2020-2028

  Martino, Tami A ^a   Tata, Nazneen ^b,c   Simpson, Jeremy A ^a   Vanderlaan, Rachel ^c   Dawood, Fayez ^d   Kabir, M Golam ^c   Khaper, Neelam ^e   Cifelli, Carlo ^b   Podobed, Peter ^a   Liu, Peter P ^b,c,d   Husain, Mansoor ^b,c,d   Heximer, Scott ^b,c   Backx, Peter H ^b,c,d   Sole, Michael J ^b,c,d,f  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e LAKEHEAD UNIVERSITY   (Canada)

^f TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

angiotensin converting enzyme inhibitors; cardiac remodeling; chronotherapy; circadian; diurnal

Indexed keywords

C 4042; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CHRONOTHERAPY; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ENZYME INHIBITION; EVENING DOSAGE; GRAVIMETRY; HEART HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; KIDNEY FUNCTION; MALE; MORNING DOSAGE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEEP TIME; TELEMETRY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DRUG CHRONOTHERAPY; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED C57BL; SLEEP; VENTRICULAR REMODELING;

EID: 79955865250     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.11.022     Document Type: Article

References (31)

1. T.A. Martino, and M.J. Sole Molecular time: an often overlooked dimension to cardiovascular disease Circ Res 105 2009 1047 1061
2. A.B. Reddy, G.K. Wong, J. O'Neill, E.S. Maywood, and M.H. Hastings Circadian clocks: neural and peripheral pacemakers that impact upon the cell division cycle Mutat Res 574 2005 76 91 (Pubitemid 40725970)
3. S.M. Reppert, and D.R. Weaver Molecular analysis of mammalian circadian rhythms Annu Rev Physiol 63 2001 647 676 (Pubitemid 32304333)
4. T. Roenneberg, and M. Merrow Timeline: circadian clocksthe fall and rise of physiology Nat Rev Mol Cell Biol 6 2005 965 971 (Pubitemid 41778715)
5. M.E. Young The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function Am J Physiol Heart Circ Physiol 290 2006 H1 H16
6. T. Martino, S. Arab, and M. Straume Day/night rhythms in gene expression of the normal murine heart J Mol Med 82 2004 256 264 (Pubitemid 38553654)
7. Y.F. Guo, and P.K. Stein Circadian rhythm in the cardiovascular system: chronocardiology Am Heart J 145 2003 779 786 (Pubitemid 36570947)
8. S.N. Willich, D. Levy, M.B. Rocco, G.H. Tofler, P.H. Stone, and J.E. Muller Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population Am J Cardiol 60 1987 801 806 (Pubitemid 17163439)
9. A. Knutsson, and H. Boggild Shiftwork and cardiovascular disease: review of disease mechanisms Rev Environ Health 15 2000 359 372 (Pubitemid 32039007)
10. J. Wang In vivo glucose monitoring: towards 'Sense and Act' feedback-loop individualized medical systems Talanta 75 2008 636 641 (Pubitemid 351484145)
11. G.A. Bjarnason, R.G. Mackenzie, and A. Nabid Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3) Int J Radiat Oncol Biol Phys 73 2009 166 172
12. V.Y. Gorbacheva, R.V. Kondratov, and R. Zhang Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex Proc Natl Acad Sci U S A 102 2005 3407 3412 (Pubitemid 40328058)
13. R.C. Hermida Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study Chronobiol Int 24 2007 749 775 (Pubitemid 47263103)
14. P. Verdecchia, G. Schillaci, and M. Guerrieri Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension Circulation 81 1990 528 536 (Pubitemid 20055961)
15. M.H. Smolensky, and E. Haus Circadian rhythms and clinical medicine with applications to hypertension Am J Hypertens 14 2001 280S 290S (Pubitemid 32868544)
16. Y.G. Qiu, J.H. Zhu, and Q.M. Tao Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled, nondipping hypertensives Cardiovasc Drugs Ther 19 2005 189 195
17. R.C. Hermida, D.E. Ayala, J.R. Fernandez, and C. Calvo Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension Hypertension 51 2008 69 76 (Pubitemid 350307106)
18. G. Bruckschlegel, S.R. Holmer, and K. Jandeleit Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats Hypertension 25 1995 250 259
19. E.O. Weinberg, F.J. Schoen, and D. George Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis Circulation 90 1994 1410 1422 (Pubitemid 24284463)
20. K.M. Baker, G.W. Booz, and D.E. Dostal Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system Annu Rev Physiol 54 1992 227 241
21. L. Mazzolai, J. Nussberger, and J.F. Aubert Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system Hypertension 31 1998 1324 1330 (Pubitemid 28248835)
22. T.A. Martino, N. Tata, and D.D. Belsham Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchronization Hypertension 49 2007 1104 1113 (Pubitemid 351664310)
23. Merck Captopril: Drug Information Provided by Lexi-Comp http://www.merck.com/mmpe/lexicomp/captopril.html Accessed March 12, 2009
24. J.J. Raia Jr., J.A. Barone, W.G. Byerly, and C.R. Lacy Angiotensin-converting enzyme inhibitors: a comparative review DICP 24 1990 506 525 (Pubitemid 20149732)
25. Y. Naito, T. Tsujino, Y. Fujioka, M. Ohyanagi, and T. Iwasaki Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats Hypertension 40 2002 827 833 (Pubitemid 35434902)
26. T.O. Morgan, J.F. Aubert, and Q. Wang Sodium, angiotensin II, blood pressure, and cardiac hypertrophy Kidney Int Suppl 67 1998 S213 S215
27. M.J. Sole, and T.A. Martino Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure J Appl Physiol 107 2009 1318 1327
28. H. Nonaka, N. Emoto, and K. Ikeda Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells Circulation 104 2001 1746 1748 (Pubitemid 32963335)
29. S. Hobbs, M.E. Thomas, and A.W. Bradbury Manipulation of the renin angiotensin system in peripheral arterial disease Eur J Vasc Endovasc Surg 28 2004 573 582 (Pubitemid 39462647)
30. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153 (Pubitemid 30051645)
31. S.E. Nissen, E.M. Tuzcu, and P. Libby Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial JAMA 292 2004 2217 2225